The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | Epigenetic alterations underlying the distinct gene expression profiles in WM
Zachary Hunter, PhD, Dana-Farber Cancer Institute, Boston, MA, speaks on epigenetic alterations that drive varied gene expression profiles in Waldenström’s macroglobulinemia (WM) progression and among its subtypes. His study utilized RNA sequencing to identify genes associated with the evolution of WM and unique transcription factor binding motifs that regulate their expression. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
